ScinoPharm Taiwan, Ltd. — Investor Relations & Filings
ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 115年第1季財務報告書 — 202601_1789_AI1.pdf | 2026-05-14 | Chinese | |
| 115年第1季海外子公司投資 | 2026-05-13 | Chinese | |
| 115年第1季大陸投資 | 2026-05-13 | Chinese | |
| 115年04月內部人持股異動(事後) | 2026-05-06 | Chinese | |
| 115年04月董事會成員及持股 | 2026-05-06 | Chinese | |
| 公告本公司法人董事改派代表人 | 2026-04-30 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46370376 | 115年第1季財務報告書 — 202601_1789_AI1.pdf | 2026-05-14 | Chinese | ||
| 46363107 | 115年第1季海外子公司投資 | 2026-05-13 | Chinese | ||
| 46362055 | 115年第1季大陸投資 | 2026-05-13 | Chinese | ||
| 41674802 | 115年04月內部人持股異動(事後) | 2026-05-06 | Chinese | ||
| 41674774 | 115年04月董事會成員及持股 | 2026-05-06 | Chinese | ||
| 39932962 | 公告本公司法人董事改派代表人 | 2026-04-30 | Chinese | ||
| 37934278 | 公告本公司115年第一季合併財務報告董事會預計召開日期 為115年05月06日 | 2026-04-28 | Chinese | ||
| 37996997 | 115年04月僑外投資持股 | 2026-04-28 | Chinese | ||
| 36166699 | 115年年報及股東會資料 — 2026_1789_20260527F13.pdf | 2026-04-24 | Chinese | ||
| 36166669 | 115年年報及股東會資料 — 2026_1789_20260527F17.pdf | 2026-04-24 | Chinese | ||
| 36166642 | 115年年報及股東會資料 — 2026_1789_20260527F01.pdf | 2026-04-24 | Chinese | ||
| 33905629 | 115年3月背書保證與資金貸與 | 2026-04-09 | Chinese | ||
| 33905621 | 115年3月營業收入 | 2026-04-09 | Chinese | ||
| 33796041 | 115年03月內部人持股異動(事後) | 2026-04-08 | Chinese | ||
| 33796038 | 115年03月董事會成員及持股 | 2026-04-08 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
ScinoPharm Taiwan, Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/51922/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=51922 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=51922 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=51922 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 51922}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ScinoPharm Taiwan, Ltd. (id: 51922)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.